Pittsburgh, PA17 Active Studies

Osteogenesis Imperfecta Clinical Trials in Pittsburgh, PA

Find 17 actively recruiting osteogenesis imperfecta clinical trials in Pittsburgh, PA. Connect with local research sites and explore new treatment options.

17
Active Trials
17
Sponsors
6,567
Enrolling

Recruiting Osteogenesis Imperfecta Studies in Pittsburgh

About Osteogenesis Imperfecta Clinical Trials in Pittsburgh

Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.

There are currently 17 osteogenesis imperfecta clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 6,567 participants. Research is being sponsored by Stanford University, University of Pittsburgh, Children's Hospital Medical Center, Cincinnati and 14 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Osteogenesis Imperfecta Clinical Trials in Pittsburgh — FAQ

Are there osteogenesis imperfecta clinical trials in Pittsburgh?

Yes, there are 17 osteogenesis imperfecta clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What osteogenesis imperfecta treatments are being tested?

The 17 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.

Data updated July 17, 2026 from ClinicalTrials.gov